
Daiichi Sankyo Company, Limited
Daiichi Sankyo Company, Limited (DSNKY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DSNKY · as of Jun 8, 2026
Key Statistics
Explore Daiichi Sankyo Company, Limited Data
dsnky stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
dsnky competitorsStock Performance
Full HistoryAbout Daiichi Sankyo Company, Limited
Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent an…
what is daiichi sankyo company, limited · dsnky stock overview · daiichi sankyo company, limited company profile · who is daiichi sankyo company, limited ceo · dsnky OTC · daiichi sankyo company, limited headquarters · daiichi sankyo company, limited business segments
About Stock Overview & Key Data
Daiichi Sankyo Company, Limited (DSNKY) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Dec 12, 2008. As of the latest trading session, DSNKY stock price is $16.13, with a market capitalization of $29.4B. The stock has returned -38.04% over the past 12 months and -27.92% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Daiichi Sankyo Company, Limited stock is Buy, with an average 12-month price target of $—. In fiscal year 2026, Daiichi Sankyo Company, Limited reported revenue of $2.25T and net income of $275.5B. For detailed data — including Daiichi Sankyo Company, Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Daiichi Sankyo Company, Limited (DSNKY) stock price is $16.13. The stock is traded on OTC under the ticker symbol DSNKY. The 52-week range is $15.10 – $27.50.